EUVIMEDEUVIMED entdecken
Open Access

Targeting ONECUT3 blocks glycolytic metabolism and potentiates anti-PD-1 therapy in pancreatic cancer

Peng-Cheng Chen, Yong Ning, Hui Li, Jin-Gen Su, Jiang-Bo Shen, Qing-Chun Feng, Shu-Heng Jiang, Pei-Dong Shi, Run-Sheng Guo

Cellular Oncology · 2024

DOI: 10.1007/s13402-023-00852-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, 2024. Verfasst von Peng-Cheng Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, 201800, P.R.…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Jiading District Medical Key Discipline Foundation of Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsCarcinoma, Pancreatic DuctalHumansCell Line, TumorCell ProliferationLactic AcidGlycolysisTumor Microenvironment

Stichwörter der Autor:innen

Cancer metabolismImmune checkpoint blockadeONECUTPancreatic cancerTumor microenvironment

Substanzen

Lactic Acid

Autor:innen und Institutionen

  • Department of General Surgery, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, 201800, P.R. China.
  • State Key Laboratory of Oncogenes and Related Genes, Ren Ji Hospital, School of Medicine, Shanghai Cancer Institute, Shanghai Jiao Tong University, Shanghai, 200240, P.R. China.
  • Department of General Surgery, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, 201800, P.R. China. shipeidong9410@163.com.
  • Department of General Surgery, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, 201800, P.R. China. grs982600@163.com.

Förderung

  • Jiading District Medical Key Discipline Foundation of Shanghai

Zitieren

APA

Chen, P. C., Ning, Y., Li, H., Su, J. G., Shen, J. B., Feng, Q. C., Jiang, S. H., Shi, P. D., & Guo, R. S. (2024). Targeting ONECUT3 blocks glycolytic metabolism and potentiates anti-PD-1 therapy in pancreatic cancer. Cellular Oncology. https://doi.org/10.1007/s13402-023-00852-3

Vancouver

Chen PC, Ning Y, Li H, Su JG, Shen JB, Feng QC, et al. Targeting ONECUT3 blocks glycolytic metabolism and potentiates anti-PD-1 therapy in pancreatic cancer. Cellular Oncology. 2024. doi:10.1007/s13402-023-00852-3

BibTeX
@article{Chen2024,
  author = {Chen, Peng-Cheng and Ning, Yong and Li, Hui and Su, Jin-Gen and Shen, Jiang-Bo and Feng, Qing-Chun and Jiang, Shu-Heng and Shi, Pei-Dong and Guo, Run-Sheng},
  title = {Targeting ONECUT3 blocks glycolytic metabolism and potentiates anti-PD-1 therapy in pancreatic cancer},
  journal = {Cellular Oncology},
  year = {2024},
  doi = {10.1007/s13402-023-00852-3}
}
Kostenlos starten →